🤩 Congratulations Dr.@ChowHanChua on receiving the prestigious @nhmrc Investigator Grant! Your research on the NALCN channel will provide critical insights into the (patho)physiological and pharmacological role of the channel in neurodevelopmental disorders 🧠💊 @Sydney_Uni
1
5
199
Congratulations!!
Publication alert 📢 Correlations of receptor desensitization of gain-of-function #GABRB3 variants with clinical severity ‼️
🇦🇺🇩🇰 teamwork💪
#Epilepsy💜
@SusanxnLin @AngeloKeramidas @Philip_K_Ahring @Vivian_WY_Liao @AbsalomNathan 👏@lundbeckfonden 🙏
academic.oup.com/brain/advan…
Congratulations @Vivian_WY_Liao! 🧠💊
Publication alert 📢 #GABRA1-related disorders: from genetic to functional pathways.
We expand the genetic and phenotypic spectrum and delineate specific sub-phenotypes for LoF and GoF variants.
Fantastic 🇩🇰🇦🇺🇮🇹 teamwork ‼️
@Elegardella @Philip_K_Ahring
onlinelibrary.wiley.com/doi/…
4
114
2023 NeuroDrug symposium hosted by @Sydney_DDI and @BrainMind_Usyd.
Thank you @Vivian_WY_Liao @DrEleanorD and @rchltan for organising such a wonderful program for EMCRs to network and collaborate with each other! 💊
DDI Symposium with Dr Vivian Liao & @Sydney_DDI
bit.ly/DrVivianLiao
✨Title: CNS Ion Channel Drug Discovery
@syd_health
7
325



